Harris & Harris Group Announces Changes to Its Legal

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Harris & Harris Group Announces Changes to Its Legal Department

NEW YORK, June 9, 2014 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq: TINY ), an investor in transformative companies enabled by disruptive science, announced today that Sandra M. Forman, its General Counsel and Chief Compliance Officer, is joining Proskauer Rose LLP as Senior Counsel. Proskauer is a global law firm with wide experience in all areas of practice important to business, including corporate finance, mergers and acquisitions, private equity, litigation and intellectual property.

Harris & Harris Group will continue to work with Ms. Forman in her new role at Proskauer. Patricia N. Egan, the Chief Financial Officer, will assume the additional role of Chief Compliance Officer beginning on July 1, 2014.

"Sandra has been a senior member of our team for ten years and was responsible for initiating and maintaining a compliance program that we believe was best-in-class and for providing sound counsel to management," said Douglas W. Jamison, Chairman and CEO of Harris & Harris Group.  "Her investment company knowledge, her business development company experience and her knowledge of compliance and regulation are extraordinary. This is a wonderful opportunity for her to advance her career at a premier law firm such as Proskauer.  It is a wonderful opportunity for Harris & Harris Group to continue to have access to her and to the other leading practices of Proskauer as well."

Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com , on Facebook at www.facebook.com/harrisharrisvc and by following us on Twitter @harrisandharrisgroup.

This press release may contain statements of a forward-looking nature relating to future events.  These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions.  These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release.  Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2013, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including, but not limited to, the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results.  Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.  The references to the websites www.HHVC.com and www.Facebook.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites.

DOUGLAS W. JAMISON TEL. NO. (212) 582-0900

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib

Updated Category News Views 264

Promising Advances in Breast Cancer Treatment Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a pioneering biopharmaceutical company specializing in breast cancer therapies, recently revealed compelling data from its Phase 1b/2 trial examining the effects of palazestrant combined with ribociclib in patients battling estrogen...

Continue Reading
Recent Share Transactions by Danske Bank Management Team

Updated Category News Views 135

Recent Share Transactions by Danske Bank Management Team Danske Bank A/S has been making headlines with its ongoing share buy-back program, a key strategic move aimed at enhancing shareholder value. As management and executives involve themselves in these transactions, it is essential to stay informed about their actions, which are a reflection of the company's health and...

Continue Reading
Purpose Legal's PurposeXi: AI-Driven Legal Revolution or Just Hype?

Updated Category News Views 171

Purpose Legal just unveiled PurposeXi™ on February 17, 2026—this shiny new tool aims to revolutionize the legal landscape by integrating AI across the board. Traders are raising eyebrows because while they tout speed and efficiency, we've seen this play before. Remember when tech made bold claims but left investors hanging when reality hit? Well, buckle up....

Continue Reading
PowerBank's Vision for Dominating the Data Center Industry

Updated Category News Views 138

Insight into the Data Center Market PowerBank Corporation (NASDAQ: SUUN) is stepping into the spotlight as a key player in the rapidly expanding data center market. The company is poised to leverage its expertise in energy infrastructure development and asset ownership to address the rising demand for power supply in data centers. Projections suggest that the data center...

Continue Reading
Exploring the Promising Landscape of Adenosine Antagonists

Updated Category News Views 156

Introduction to Adenosine Antagonists Adenosine antagonists represent a fascinating domain in medical research, particularly due to their potential implications across various therapeutic areas. As these compounds inhibit adenosine—a nucleoside that governs essential physiological functions—they may revolutionize treatment options for diseases such as cancer,...

Continue Reading